Danaher Earnings Due at 6 AM: Six-Quarter Beat Streak at Stake

As seen on the 24/7 Wall St. homepage on October 21, 2026.

DHR Danaher Corporation
Reports Wed Oct 21 Before open 6:00 AM ET Confirmed

Danaher reports at 6:00 AM ET with a six-quarter EPS beat streak on the line, and consensus sits at $1.92. Bioprocessing commentary here sets the tone for the entire life science tools group.

    Continue ReadingShow less

    Danaher reports before the open on October 21, 2026, at 6:00 AM ET, carrying a six-quarter streak of beating expectations into the release.

    Consensus sits at $1.92 in earnings per share, a bar the streak has already raised for what the market treats as a satisfactory outcome.

    Management's commentary on bioprocessing has a history of moving the entire life science tools sector, including peers that have not yet reported.

    With the opening bell close behind, any surprise shows up in pre-market trading almost immediately, making this an early read on sector demand.

    Sources

    Mentioned: DHR

    Related Market Updates

    DHR Danaher
    Regular session
    $230.40
    +5.22% open $218.97
    $235$230$225

    A 5.2% jump to $230.40 is an outsized day for a $162 billion life sciences name, and it lands with earnings due today. That sets a high bar for the report to clear.

    Read more
    DHR Danaher
    Regular session
    $231.48
    +5.71% open $218.97

    A 5.7% intraday jump to $231.48 is a rare one-day move for a $163 billion life sciences name, and it lands on the same day Danaher reports earnings. The results and outlook now have to justify the repricing.

    Read more
    New insider tie · Form 3 Robert Hershberg
    Now director at DANAHER CORP /DE/

    A new name on the board of a $161 billion life sciences giant is worth tracking, because board seats at Danaher tend to precede capital allocation shifts in diagnostics and biotech tools. Hershberg's first Form 3 puts his future buys and sells on the public record from here on.

    Read more
    New insider tie · Form 3 Daniel L Comas
    Now director at DANAHER CORP /DE/

    Danaher's former longtime finance chief is back inside the house, this time in the boardroom, just as the $161 billion group digests its $10 billion Masimo purchase. An insider who knows the company's capital allocation playbook cold now has a vote on the next deal.

    Read more
    Polymarket @polymarket

    Danaher is moving from selling lab instruments to running the lab itself, putting its AI ambitions directly against drug-discovery software rivals.

    JUST IN: Danaher unveils plans for an autonomous AI research lab combining robotics and AI to design, build, & test new molecules with minimal human intervention.
    • Replies9
    • Reposts5
    • Likes37
    Read more
    Biggest movers · At the close
    Gainers
    • ACNAccenture$211.97+15.6%
    • SNPSSynopsys$490.81+12.8%
    • COHRCoherent$318.52+10.7%
    • AAOIApplied Optoelectronics$107.16+8.0%
    • LITELumentum$1,043.95+7.5%
    Losers
    • AMCAMC Entertainment$2.75-8.2%
    • TEMTempus AI$76.51-6.6%
    • BRKRBruker$61.76-4.6%
    • DHRDanaher$211.34-4.6%
    • NWGNatWest Group$17.36-4.3%

    Three names in our 383-stock board closed with double-digit gains, led by Accenture's 15.6% jump to $211.97, a move that size is rare for a mega-cap consultant. The downside was far tamer, with AMC's 8.2% slide the worst of it.

    Read more